Term
|
Definition
{(%neutrophila +%bands) xWBX]/100 |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
the degree of neutropenia shows your- |
|
Definition
|
|
Term
chemo induced neutropenia depdns on what factors?-4 |
|
Definition
type of chemoc pretreatment presence of cancer in bone marrow age |
|
|
Term
what is the most common DOSE LIMITNG tox of chemo? |
|
Definition
neutropenia/infection (morbidity and mortality) |
|
|
Term
most chemo cause nadir btwn days- recovery by day |
|
Definition
|
|
Term
|
Definition
there is lowest amnt of neutrophils |
|
|
Term
consequuences of neutropenia is increased-3 |
|
Definition
infx, ANX, hospitlization |
|
|
Term
conseq. of neutropenia is compromised- |
|
Definition
tx effiacy due to dose decreases |
|
|
Term
to prevent neutropeniawhat two things cna be done |
|
Definition
dose reeduction hematooeotic growth factors (CSF) |
|
|
Term
For tx of neutropenia, what 3 things are done |
|
Definition
hospitlization ABX if febrile hematopeotic growth factors |
|
|
Term
the G-CSF (gnulocytte stim factor) is 3 things-3 |
|
Definition
glycoportine growth factor cytokine |
|
|
Term
G-CSF is normally produce by? |
|
Definition
|
|
Term
G-CSF recpt is on bone marrow, if stimualted what can it do-2 |
|
Definition
proliferation of granulocuytes bone marrow cell rlease |
|
|
Term
G-CSF signal pathway invovles what molcules-3 |
|
Definition
JACK/STAT RAS/MAPK PI3K/Protein kinase B (Akt) |
|
|
Term
_ G CSF stimulates rpoduction of neutrophuls |
|
Definition
filgrastim (and pegylates form pregrilgrastim) |
|
|
Term
_ G cSF stimulates myelopoeisis |
|
Definition
|
|
Term
|
Definition
psot chemo febrile nuetropenia post inducer of hematopeotic stem cells for stem cell trnasplantation |
|
|
Term
G CSf is used for chemo febril enutropenia when-3 |
|
Definition
risk is 20% and no other regimen doesnt compromise dose intensity reduces dose delya |
|
|
Term
G CSF is sued in primary prophylaxis when- |
|
Definition
POSt -CT before neutropenia |
|
|
Term
G CSF is used as secdonary prophylaxis when- |
|
Definition
post CT pt with previeoius neutropenia from CT |
|
|
Term
Use primary prohpylaxis G CSF when: CT and risk of FN >20% |
|
Definition
|
|
Term
Use primary prohpylaxis G CSF when: CT and risk of FN 10-20% |
|
Definition
use if other risk factors (age, hx, etc) |
|
|
Term
Use primary prohpylaxis G CSF when: CT and risk of FN <10% |
|
Definition
Never (only if complications start) |
|
|
Term
when is C-CSF agents used after chemo? |
|
Definition
|
|
Term
filgrastim is dosed how mnay times per day and howmnay days? how long does a dose last? |
|
Definition
|
|
Term
filgrastim is for inpt/outpt which med is for the other? |
|
Definition
inpatient pegylated is for outpat |
|
|
Term
Pegylated filgrastim is dosed how much? |
|
Definition
|
|
Term
Sargromostim us used when? |
|
Definition
after BM tnrasplant if pt has fungal infx |
|
|
Term
|
Definition
post chemo as primary prevetnion of FN chronic neutropenia stem cell trnaspl pierpiheral mobilization |
|
|
Term
sargamostim is only indicated in pediatrics/adults after _ indcution therapy |
|
Definition
|
|
Term
Filgrastim dosing how admin? max if <132 lbs, if >? |
|
Definition
5 mcg/kg per day SQ 300, 480 |
|
|
Term
Dosing pegfilgrastim admin? |
|
Definition
|
|
Term
whcih G CSf has longest half life |
|
Definition
|
|
Term
dosing of Sargramostim admin? |
|
Definition
|
|
Term
|
Definition
sickel cell anaphylaxis resp splenic rupture |
|
|
Term
Chemo Tx with high risk for nuetropenia:-6 |
|
Definition
(Non- Hgokins CHOP, ICe, RICE) cyclophosphamide, etoposide, cisplatin, paclitexal +cisplatin, topotecan Taxane +dox +/- cyclpphos |
|
|
Term
clincial pearls about G CSFs- are admin _ chemo no change in infx/overall omrtality w/? which is better? |
|
Definition
24 hrs post treat,ent prevention! |
|
|
Term
what is proimary issue with G CSFs? |
|
Definition
|
|
Term
|
Definition
esophagus, duodenum, ileum, colon, rectum, stomach |
|
|
Term
|
Definition
infalmm of mucus surfaces in body |
|
|
Term
what disease invovles red ulcerative sores? |
|
Definition
|
|
Term
oral mucosisits manifests as-3 |
|
Definition
erythemia, ulcers, hemorrhage |
|
|
Term
mucosisits is damage to_ of what places why? |
|
Definition
epitheloum GI, oralpharyngeal chemo affects the rapid dividing cells of muscus |
|
|
Term
|
Definition
|
|
Term
|
Definition
signaling with messengers |
|
|
Term
|
Definition
amplificaiton of apopotosis/bacterium invades |
|
|
Term
|
Definition
fungus invades/ulceration |
|
|
Term
|
Definition
|
|
Term
oral mucosists is most common* *also more aggreive in this one |
|
Definition
|
|
Term
*can get nasal and vaginal mucosistis |
|
Definition
|
|
Term
Grade _ mucosists:
painless ulcers, mild soreness |
|
Definition
|
|
Term
Grade _ mucosists: painrful esema or ulvers but eating possible |
|
Definition
|
|
Term
Grade _ mucosists: painful edema/ulcers, require IV eating |
|
Definition
|
|
Term
Grade _ mucosists: severe ulcers requiring TPN or intubaiton for feeds |
|
Definition
|
|
Term
|
Definition
pain diff eating adb pain diarrhea |
|
|
Term
complicaitons of mucosistis-3 |
|
Definition
bactermia/sepsis poor nutrition decrease activty/QOL |
|
|
Term
what class of agnets are used to tx mucosistis |
|
Definition
keratinocyte growth factor (KGF) |
|
|
Term
|
Definition
decrease DNA damage increase detox enzyme to protect from ROS decrease pro inflamm cytokines decrease apoptosis |
|
|
Term
KGF doesnt have evidence for use in what-2 why? |
|
Definition
chemo only regimens solid tumors may increase tumor growth |
|
|
Term
KGF jas indicaitons for us in-3 |
|
Definition
hametologic malignancy high dose chemo + total body irridation stem cell trnasplant |
|
|
Term
Palifermin (Kepivance) is- |
|
Definition
|
|
Term
|
Definition
60 mcg/kg/day x 3 day before and smae x 3 days after |
|
|
Term
|
Definition
|
|
Term
plaifermin shoundlnt be admin _ chemo |
|
Definition
24 hrs before, during, or after meyelotoxic |
|
|
Term
palifermin is contradinciated ni what person |
|
Definition
allergic to E. coli protein |
|
|
Term
|
Definition
thick tongue/discolor taste disturbance amylase/lipase elevation |
|
|